Showing results (91-100 of 120) with videos related to
Sort By:
Pageof 12
Breast Cancer Research and Treatment|December 24, 2008
Immunohistochemical validation of multiple phospho-specific epitopes for estrogen receptor alpha (ERalpha) in tissue microarrays of ERalpha positive human breast carcinomasGeorge P Skliris, Brian G Rowan, Mariam Al-Dhaheri, et al.Biorxiv : the Preprint Server for Biology|November 24, 2025
Autophagy disruption primes CAR-T cell metabolism for sustained rejection of ovarian tumorsGillian A Carleton, Sébastien Levesque, Lauren G Zacharias, et al.Biochemical and Biophysical Research Communications|February 5, 2003
Identification of new human coding steroid receptor RNA activator isoformsEthan Emberley, Guo-Jian Huang, Mohammad K Hamedani, et al.Biopreservation and Biobanking|August 31, 2016
Biospecimen User Fees: Global Feedback on a Calculator ToolLise A M Matzke, Sindy Babinszky, Alex Slotty, et al.Cancer Research|July 5, 2005
The S100A7-c-Jun activation domain binding protein 1 pathway enhances prosurvival pathways in breast cancerEthan D Emberley, Yulian Niu, Linda Curtis, et al.The Journal of Pathology|September 22, 2012
Clonal evolution of high-grade serous ovarian carcinoma from primary to recurrent diseaseMauro Castellarin, Katy Milne, Thomas Zeng, et al.The Journal of Steroid Biochemistry and Molecular Biology|May 12, 2009
The relevance of phosphorylated forms of estrogen receptor in human breast cancer in vivoLeigh C Murphy, Georgios P Skliris, Brian G Rowan, et al.Breast Cancer Research : BCR|September 11, 2009
Steroid Receptor RNA Activator Protein (SRAP): a potential new prognostic marker for estrogen receptor-positive/node-negative/younger breast cancer patientsYi Yan, George P Skliris, Carla Penner, et al.Cancer Research|October 19, 2006
Estrogen receptor-alpha phosphorylated at Ser118 is present at the promoters of estrogen-regulated genes and is not altered due to HER-2 overexpressionGregory E Weitsman, Lin Li, George P Skliris, et al.Biochemistry|October 9, 2009
Identification and characterization of binding sites on S100A7, a participant in cancer and inflammation pathwaysRafael León, Jill I Murray, Gina Cragg, et al.Pageof 12